107 filings
Page 5 of 6
8-K
7yagwr cm2vp
12 Aug 20
Vaxcyte Reports Second Quarter 2020 Financial Results and Provides Business Update
4:24pm
10-Q
uxef0627zitmzp3ohdx
12 Aug 20
Quarterly report
4:01pm
8-K
luc6e1t
16 Jun 20
Amendments to Articles of Incorporation or Bylaws
4:30pm
424B4
toc yy4hlu2
15 Jun 20
Prospectus supplement with pricing info
5:17pm
S-8
i1uak bw68
12 Jun 20
Registration of securities for employees
4:14pm
EFFECT
az05r5ux2ytc
12 Jun 20
Notice of effectiveness
12:15am
S-1MEF
f1x9uhmvqvh7tx3cui
11 Jun 20
Registration of additional securities for an S-1
9:46pm
CERT
gt6t5dfds9c
10 Jun 20
Certification of approval for exchange listing
10:10am
8-A12B
k2av w9ki
9 Jun 20
Registration of securities on exchange
4:01pm
CORRESP
qjjai mbv2iv40xcp5g
9 Jun 20
Correspondence with SEC
12:00am
CORRESP
rgzjbsip
9 Jun 20
Correspondence with SEC
12:00am
S-1/A
zq2m1ghj onrt
8 Jun 20
IPO registration (amended)
6:31am
S-1
j2qw884luhg5bjgug27
22 May 20
IPO registration
5:01pm
CORRESP
cp8jsje vk0nk
22 May 20
Correspondence with SEC
12:00am
D
y8y 4kax202k
3 Apr 20
$110M in equity, sold $110M, 23 investors
2:28pm
UPLOAD
qlj 08cmmmoktxqct
27 Mar 20
Letter from SEC
12:00am
DRSLTR
ihmpo
13 Mar 20
Correspondence regarding draft registration statement
12:00am
DRS/A
3nw9ua 15qtlf
13 Mar 20
Draft registration statement (amended)
12:00am
UPLOAD
ebvcvugms6lhz
21 Jan 20
Letter from SEC
12:00am